FDA Authorizes Johnson & Johnson COVID-19 Vaccine

Date: March 22, 2021 Issue #: 1620Summary: On February 27, 2021, the FDA issued an Emergency Use Authorization (EUA) for the Johnson& Johnson adenovirus-based vaccine for prevention of COVID-19 in persons ≥18 years old. It is the third COVID-19 vaccine to become available in the US and the first to require only a single dose. Two-dose mRNA-based vaccines manufactured by Pfizer-BioNTech and Moderna received EUAs in December 2020.

http://secure.medicalletter.org/TML-article-1620a

Source: The Medical Letter - February 4, 2021 Category: Drugs & Pharmacology Authors: admin Tags: COVID-19 vaccines Source Type: research